Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
Neuronetics (STIM) reported a Q3 loss of $0.29 per share, missing the Zacks Consensus Estimate of a $0.23 loss. This is an improvement from the $0.33 loss per share a year ago.
November 12, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Neuronetics reported a Q3 loss of $0.29 per share, which was worse than the expected loss of $0.23 per share. However, this is an improvement from the $0.33 loss per share a year ago.
The reported loss per share was worse than expected, which is typically negative for stock prices. However, the loss is smaller compared to the previous year, indicating some improvement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100